Fig. 1 · Structure
Documents & Downloads
Caracemide
Ribonucleotide Reductase Inhibitor
Caracemide is a ribonucleotide reductase inhibitor derived from hydroxamic acid. It exhibits significant biological activity as an anticancer agent and has been shown to produce severe central nervous system (CNS) toxicity. This compound is of particular interest for research applications focused on cancer therapeutics and the investigation of enzyme inhibition mechanisms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 81424-67-1 |
| Applications | Ribonucleotide Reductase Inhibitor |
| Formula | C6H11N3O4 |
| Molecular Weight | 189.17 |
| Synonyms | NSC-253272 |
| SMILES | CC(N(OC(NC)=O)C(NC)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.